Literature DB >> 2853014

The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance of CMV-latency and its influence on immunocompetence.

H W Roenhorst1, C G Kallenberg, T H The.   

Abstract

Development and maintenance of cellular immunity to cell-associated CMV-antigens (CMVFF) was investigated in non-immunocompromised hosts during the first year (group I, n = 11) and 1 to 5 years (group II, n = 9) after a symptomatic primary CMV infection, as well as in healthy CMV-seropositive controls without a history of CMV disease (group III, n = 28). During the acute phase (0-2 months) of a primary CMV-infection CMVFF-induced lymphocyte proliferation was severely decreased compared to that in the post-illness phase (5-12 months), and to that in groups II and III. After the reconvalescent period (3-4 months) it gradually increased to levels seen in group III. In group II higher responses to CMVFF were found than in group III or during the post-illness phase of a primary infection. In general CMV-virion induced lymphocyte proliferation showed the same pattern of development as the CMVFF-induced lymphocyte response, but during the acute phase (0-2 months) a lack of correlation was observed between lymphocyte proliferation to CMVFF and CMV-virions. Lymphocyte proliferation to PHA, Con A, allogeneic lymphocytes and recall antigens were severely depressed in the acute phase of a primary CMV-infection and restored gradually to levels seen in groups II and III, with the exception of Con A-reactivity. The latter response remained depressed when compared to healthy seropositive controls, not only during the post-illness period, but also later on (group II).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2853014      PMCID: PMC1542018     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

Review 1.  Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections.

Authors:  S Stagno; R J Whitley
Journal:  N Engl J Med       Date:  1985-11-14       Impact factor: 91.245

2.  Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay.

Authors:  J M Middeldorp; J Jongsma; A ter Haar; J Schirm; T H The
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

3.  Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection.

Authors:  H W Roenhorst; J M Middeldorp; J M Beelen; J Schirm; A M Tegzess; T H The
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

4.  Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products.

Authors:  G P Rice; R D Schrier; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

5.  Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection.

Authors:  M J Reddehase; U H Koszinowski
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

6.  Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity.

Authors:  L K Borysiewicz; S Morris; J D Page; J G Sissons
Journal:  Eur J Immunol       Date:  1983-10       Impact factor: 5.532

7.  Monocyte-derived inhibitor of interleukin 1 induced by human cytomegalovirus.

Authors:  B C Rodgers; D M Scott; J Mundin; J G Sissons
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

8.  Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection.

Authors:  R D Schrier; J A Nelson; M B Oldstone
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

9.  Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. II. Secondary CMV infections associated with impaired in vitro proliferative responses to mitogens, allogeneic lymphocytes and CMV infected cells.

Authors:  H W Roenhorst; J M Beelen; J M Middeldorp; J Schirm; A M Tegzess; T H The
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

10.  Blastogenic response of human lymphocytes to early antigen(s) of human cytomegalovirus.

Authors:  J L Waner; N Kong; S Biano
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more
  1 in total

Review 1.  Cofactors that may influence vaccine responses.

Authors:  Guy de Bruyn
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.